News - MedTech

AI drug discovery company raises £378m Series D

SoftBank has backed an Oxford-based AI drug discovery company in a Series D funding round wor...

Ex-Dyson lead joins BioTech targeting rare diseases

Cambridge BioTech Healx has appointed a former key figure at Dyson as VP of artificial intelligenc...

‘Plastic antibodies’ may improve accuracy of rapid COVID-19 tests

A BioTech company which produces synthetic antibodies has launched a new product that could improv...

BioTech’s nasal spray ‘could stop COVID-19 in its tracks’

A team of scientists from the University of Bristol have announced the formation of a new BioTech ...

Metrion Biosciences closes £2.7m equity financing

A specialist drug discovery company has secured £2.7 million in new equity financing.  Metrion�...

European health giant snaps up BioTech in £1bn deal

A Cambridge biopharmaceutical company has been acquired in a deal potentially worth £1 billion by ...

Origami-engineered device ‘could prevent brain haemorrhage’

An Oxford University spin-out has raised £7.3 million to develop a device which could prevent brai...

BioTech behind COVID-19 tracking to float in London

Oxford Nanopore Technologies has revealed plans to float on the London Stock Exchange later this ...

Can BioTech halt disease which has led to slaughter of 300,000 cattle?

A BioTech company which has developed a rapid test that could be a ‘game-changer’ in combating...

Tech-enabled weight loss capsule is ‘safe and affordable’

Oxford Medical Products has raised £1.2 million to develop a weight loss technology which could hel...

New financing for cancer-fighting DNA start-up NeoPhore

A BioTech which effectively forces cancer cells to reveal themselves to patients’ immune syste...

Cancer-fighting start-up Ibex Medical Analytics raises $38m

AI-powered cancer diagnostics pioneer Ibex Medical Analytics has raised $38 million in a Serie...